DK1124577T3 - Anvendelse af et enterobakterielt OmpA-protein til specifik måling til antigenpræsenterende celler - Google Patents

Anvendelse af et enterobakterielt OmpA-protein til specifik måling til antigenpræsenterende celler

Info

Publication number
DK1124577T3
DK1124577T3 DK99971719T DK99971719T DK1124577T3 DK 1124577 T3 DK1124577 T3 DK 1124577T3 DK 99971719 T DK99971719 T DK 99971719T DK 99971719 T DK99971719 T DK 99971719T DK 1124577 T3 DK1124577 T3 DK 1124577T3
Authority
DK
Denmark
Prior art keywords
antigen
protein
presenting cells
enterobacterial
ompa
Prior art date
Application number
DK99971719T
Other languages
Danish (da)
English (en)
Inventor
Jean-Yves Bonnefoy
Sybille Lecoanet
Jean-Pierre Aubry
Pascale Jeannin
Thierry Baussant
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK1124577T3 publication Critical patent/DK1124577T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99971719T 1998-11-06 1999-11-08 Anvendelse af et enterobakterielt OmpA-protein til specifik måling til antigenpræsenterende celler DK1124577T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814007A FR2785542B1 (fr) 1998-11-06 1998-11-06 UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
PCT/FR1999/002734 WO2000027432A1 (fr) 1998-11-06 1999-11-08 UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE VERS LES CELLULES PRESENTATRICES D'ANTIGENES

Publications (1)

Publication Number Publication Date
DK1124577T3 true DK1124577T3 (da) 2003-12-08

Family

ID=9532467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99971719T DK1124577T3 (da) 1998-11-06 1999-11-08 Anvendelse af et enterobakterielt OmpA-protein til specifik måling til antigenpræsenterende celler

Country Status (14)

Country Link
EP (1) EP1124577B1 (zh)
JP (1) JP2002529428A (zh)
CN (1) CN1181890C (zh)
AT (1) ATE247978T1 (zh)
AU (1) AU764205B2 (zh)
BR (1) BR9915071A (zh)
CA (1) CA2350183A1 (zh)
DE (1) DE69910809T2 (zh)
DK (1) DK1124577T3 (zh)
ES (1) ES2205946T3 (zh)
FR (1) FR2785542B1 (zh)
PT (1) PT1124577E (zh)
WO (1) WO2000027432A1 (zh)
ZA (1) ZA200103478B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
FR2790959B1 (fr) * 1999-03-15 2003-06-27 Pf Medicament Utilisation de fractions membranaires bacteriennes a effet adjuvant, leurs procedes de preparation et composition pharmaceutique les contenant
EP1210114A4 (en) * 1999-08-20 2004-01-02 Gen Hospital Corp OUTER MEMBRANE PROTEIN A, PEPTIDOGLYCAN ASSOCIATED LIPOPROTEIN AND MUREINLIPOPROTEIN AS THERAPEUTIC OBJECTIVES FOR THE TREATMENT OF SEPSIS
FR2803302B1 (fr) * 2000-01-04 2004-12-10 Pf Medicament Procede de preparation d'un polypeptide soluble en solvant aqueux en absence de detergent
FR2809014A1 (fr) * 2000-05-16 2001-11-23 Pf Medicament Utilisation d'une proteine ompa d'enterobacterie comme agent antimicrobien
FR2822071B1 (fr) * 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
EP2377883A1 (en) * 2010-04-15 2011-10-19 Universite d'Auvergne Clermont I Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
CN102286106B (zh) * 2011-07-11 2013-05-01 中国人民解放军军事医学科学院微生物流行病研究所 夹心外膜蛋白展示载体及应用其制备的大肠埃希菌疫苗
KR20170011221A (ko) * 2015-07-22 2017-02-02 이화여자대학교 산학협력단 클렙시엘라균 감염질환의 예방용 백신

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
US5853719A (en) * 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
FR2748476B1 (fr) * 1996-05-07 1998-08-14 Pf Medicament Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant

Also Published As

Publication number Publication date
EP1124577A1 (fr) 2001-08-22
ZA200103478B (en) 2002-02-12
ES2205946T3 (es) 2004-05-01
CA2350183A1 (fr) 2000-05-18
EP1124577B1 (fr) 2003-08-27
FR2785542B1 (fr) 2001-02-09
CN1181890C (zh) 2004-12-29
BR9915071A (pt) 2001-07-17
DE69910809T2 (de) 2004-06-17
FR2785542A1 (fr) 2000-05-12
PT1124577E (pt) 2004-01-30
ATE247978T1 (de) 2003-09-15
AU764205B2 (en) 2003-08-14
DE69910809D1 (de) 2003-10-02
AU1164100A (en) 2000-05-29
CN1326360A (zh) 2001-12-12
WO2000027432A1 (fr) 2000-05-18
JP2002529428A (ja) 2002-09-10

Similar Documents

Publication Publication Date Title
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
DE69835201D1 (en) Neoglycoproteine
DE69835692D1 (de) Geladene lipide und deren verwendung
FR2727689B1 (zh)
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
NO962791D0 (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
ATE216590T1 (de) Arzneimittelformulierungen für il-12
DK0749317T3 (da) Terapeutiske anvendelser af dimerprodukter af baktericidt/permeabilitetsforøgende protein
MY131095A (en) Polyethylene protein conjugates.
ATE232396T1 (de) Oxydiertes thymosin beta 4
IL132951A0 (en) Compounds preparation and use for transferring nucleic acids into cells
IL138424A (en) Covalently reactive antigen analogs and pharmaceutical compositions containing the same
DK1124577T3 (da) Anvendelse af et enterobakterielt OmpA-protein til specifik måling til antigenpræsenterende celler
ATE371031T1 (de) Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs
DE69528080D1 (de) Lösliche arzneizusammensetzungen enthaltend 2-chloro-2'-deoxyadenosine
ZA200106725B (en) Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral antiparasitic or antitumoral cytotoxic response.
YU58600A (sh) Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
ATE232738T1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
PT1150716E (pt) Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao
PT980379E (pt) Oligonucleotidos quimericos e sua utilizacao
UA26246C2 (uk) Коhтрацептивhий комбіhоваhий препарат
MX9803093A (es) Suministro de polipeptidos biologicamente activos.